Poliomyelitis Market Size, Share, Trends and Forecasts, H1 2016: Radiant Insights

Submitted by: Submitted by

Views: 10

Words: 1053

Pages: 5

Category: Business and Industry

Date Submitted: 05/31/2016 11:19 PM

Report This Essay

Poliomyelitis Global Clinical Trials Review, H1 - Market Current Trends,

Size, Share, Industry Analysis, Competitive Intelligence, Growth,

Opportunities and Forecasts To 2016

Summary

GlobalData's clinical trial report, "Poliomyelitis Global Clinical Trials Review, H1, 2016"

provides an overview of Poliomyelitis clinical trials scenario. This report provides top line data

relating to the clinical trials on Poliomyelitis. Report includes an overview of trial numbers and

their average enrollment in top countries conducted across the globe. The report offers coverage

of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and

sponsor type. Report also provides prominent drugs for in-progress trials (based on number of

ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary

database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different

clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database

undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter

strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and

relevance of data for the indicated disease.

Access Full Report: http://www.radiantinsights.com/research/poliomyelitis-global-clinicaltrials-review-h1-2016

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial

Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status)

pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn)

with reason for unaccomplishment

- The Report provides...